Columbia Partners Investment Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
EIP
Columbia Partners Investment Management's CLB Position: Q4 2018 in Review
Columbia Partners Investment Management reduced its Core Laboratories (CLB) stake by 20% in Q4 2018, selling an estimated $1.15M and leaving 54,495 shares worth $3.25M. The position accounts for 1.26% of the portfolio, ranked #17.
Columbia Partners Investment Management first reported a position in CLB in Q2 2013 and has held it in 23 quarters since. The position peaked at $65.4M in Q3 2013. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.
- Columbia Partners Investment Management held 54,495 shares of Core Laboratories worth $3.25M as of Q4 2018.
- Columbia Partners Investment Management sold 13,352 Core Laboratories shares in Q4 2018, an estimated $1.15M.
- Core Laboratories made up 1.26% of Columbia Partners Investment Management's portfolio in Q4 2018, its #17 holding.
- Columbia Partners Investment Management first reported a position in Core Laboratories in Q2 2013 and has held it in 23 quarters since.
- Columbia Partners Investment Management's Core Laboratories position peaked at $65.4M in Q3 2013.
- 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.
Based on Columbia Partners Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.